Вторник, 26 Октября, 2021

What is Recommendation from Analysts on Quintiles IMS Holdings Inc (NYSE:Q)?

Manuel Armenta | 17 Февраля, 2017, 15:42

The heightened volatility saw the trading volume jump to 36,15,777 shares. Quintiles Transitional Holdings updated its Q1 guidance to $0.93-0.97 EPS and its FY17 guidance to $4.40-4.55 EPS. Bessemer Group Inc. purchased a new position in shares of Quintiles Transitional Holdings during the fourth quarter worth approximately $136,000. However the company's price to cash per share for most recent quarter stands at 15.20. To aid investors and analysts with year-over-year comparability for the merged business, we are providing combined company financial information, which combines the stand-alone Quintiles and IMS Health financial information for revenue and Adjusted EBITDA as if the merger had taken place on January 1, 2015, with conforming adjustments to the current year presentation. Daiwa Securities Group Inc. now owns 35,150 shares of the company's stock worth $2,296,000 after buying an additional 33,250 shares during the last quarter. Toronto Dominion Bank now owns 1,272 shares of the company's stock worth $103,000 after buying an additional 780 shares during the last quarter.

About QUINTILES IMS HOLDINGS, INC. (NYSE:Q) traded -1.26%. Covering analysts are predicting the stock to move to $83.94 within the next year. Earlier the firm had a rating of "Neutral " on the company shares. The stock has a market capitalization of $18.68 billion, a price-to-earnings ratio of 23.33 and a beta of 0.69. With the last close up 6.83% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.06% over the same time period. Finally, S&CO Inc. bought a new stake in shares of Quintiles Transitional Holdings during the third quarter worth approximately $243,000.

Quintiles Transitional Holdings (NYSE:Q) last announced its earnings results on Wednesday, November 2nd. The company is expected to release $1.05 EPS for current quarter according to 12 analysts whereas the company reported $0.89 EPS during same quarter a year ago. According to their observations and findings, the stock could provide a high EPS of $1.11/share and a Low EPS of $1.04/share. Quintiles Transitional Holdings's revenue was up 3.9% compared to the same quarter a year ago. During the same quarter in the prior year, the firm posted $0.94 EPS.

There were more than a few analysts who recently mentioned the stock in their research.

Based on several research reports, Shares were Downgraded by Deutsche Bank on Feb 3, 2017 to " Hold" and Lowered the Price Target to $ 80 from a previous price target of $81.Quintiles Transnational Holdings Inc was Downgraded by Goldman to " Neutral" on Dec 16, 2016. Citigroup Inc. downgraded Quintiles Transitional Holdings from a "strong-buy" rating to a "market perform" rating in a report on Thursday, December 1st. Quintiles Transnational Holdings Inc was Downgraded by Raymond James to " Mkt Perform" on Dec 1, 2016. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. Mizuho initiated coverage on Quintiles Transitional Holdings in a research report on Tuesday, December 13th.

According to the latest research reports released, 3 analysts have issued a rating of "buy", 5 analysts "outperform", 13 analysts "hold", 0 analysts "underperform" and 0 analysts "sell".

07/27/2016 - Quintiles Transitional Holdings Inc. had its "hold" rating reiterated by analysts at Evercore ISI. Following the completion of the transaction, the director now owns 2,930 shares of the company's stock, valued at $233,726.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Quintiles IMS Holdings Inc, formerly Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. It is engaged in the development and commercialization of pharmaceutical therapies.